Wilson Sonsini Goodrich & Rosati advised Ahren, OMX Ventures, +ND Capital, and Fine Structures Ventures on the transaction. Constructive Bio, a pioneering synthetic genomics company, announced...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised CellPoint on the deal. Walder Wyss has advised +ND Capital, while Baker McKenzie advised CellPoint and AboundBio. Galapagos, a fully...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised +ND Capital and the other sellers in the transaction. Novartis has acquired Arctos Medical, adding a pre-clinical optogenetics-based AAV gene therapy program and...
You must be a Standard 1 Year member to access this content.
